# Colchicine in HFpEF

> **NCT04857931** · PHASE2 · TERMINATED · sponsor: **Montreal Heart Institute** · enrollment: 14 (actual)

## Conditions studied

- Heart Failure
- Inflammation
- Colchicine

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04857931
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-17
- **Primary completion:** 2023-03-07
- **Final completion:** 2023-03-07
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Lack of funds to support opening of new sites to help patient recruitment, which was found to be more challenging than initially expected.
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04857931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04857931, "Colchicine in HFpEF". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04857931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*